Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Johnson and Johnson
McKinsey
Colorcon
Harvard Business School

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pf-04531083

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Pf-04531083?

Pf-04531083 is an investigational drug.

There have been 6 clinical trials for Pf-04531083. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2011.

The most common disease conditions in clinical trials are Chronic Pain, Toothache, and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There are twenty-four US patents protecting this investigational drug and two hundred and seventy-eight international patents.

Recent Clinical Trials for Pf-04531083
TitleSponsorPhase
Efficacy Of Pf-04531083 In Treating Post-Surgical Dental PainPfizerPhase 2
Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized SkinPfizerPhase 1
A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.PfizerPhase 1

See all Pf-04531083 clinical trials

Clinical Trial Summary for Pf-04531083

Top disease conditions for Pf-04531083
Top clinical trial sponsors for Pf-04531083

See all Pf-04531083 clinical trials

US Patents for Pf-04531083

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pf-04531083   Start Trial Substituted pyridazines for the treatment of pain INHIBITAXIN LIMITED (Sandwich Kent, GB)   Start Trial
Pf-04531083   Start Trial Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (Boston, MA)   Start Trial
Pf-04531083   Start Trial Pyridine derivatives Pfizer Inc. (New York, NY)   Start Trial
Pf-04531083   Start Trial Sulfonamide derivatives Pfizer Limited (Sandwich, GB) Icagen, Inc. (Durham, NC)   Start Trial
Pf-04531083   Start Trial Sulfonamide derivatives Pfizer Limited (Sandwich, GB) Icagen, Inc. (Durham, NC)   Start Trial
Pf-04531083   Start Trial Sulfonamide derivatives as Nav 1.7 inhibitors Pfizer Limited (Sandwich, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pf-04531083

Drugname Country Document Number Estimated Expiration Related US Patent
Pf-04531083 Canada 2853231 2031-10-28   Start Trial
Pf-04531083 China 103958481 2031-10-28   Start Trial
Pf-04531083 China 106220572 2031-10-28   Start Trial
Pf-04531083 European Patent Office 2771325 2031-10-28   Start Trial
Pf-04531083 European Patent Office 3243815 2031-10-28   Start Trial
Pf-04531083 Spain 2648901 2031-10-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Johnson and Johnson
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.